HitGen, Inc. Hits Day High with Strong 5.3% Intraday Surge

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, with its stock climbing 5.3% to reach an intraday high of CNY 32.34. This performance stands out against the backdrop of the China Shanghai Composite, which only increased by 0.87% on the same day. Over the past week, HitGen has demonstrated a robust performance, gaining 5.69%, while its one-month performance reflects a notable increase of 14.91%. The company has also excelled over the past year, with a remarkable growth of 99.62%, significantly outperforming the China Shanghai Composite's 21.68% increase. Financial metrics indicate a strong position for HitGen, with a net profit growth of 114.98% reported in September. The company achieved its highest operating cash flow at CNY 204.8 million and a return on capital employed (ROCE) of 8.01%. Additionally, the pre-tax profit for the quarter reached CNY 43.75 million, marking a substantial growth of 150.73%. With a market capitalization of CNY 11,980 million and a price-to-earnings ratio of 74.00, HitGen continues to solidify its standing in the market as a reliable performer.